WOLVERINE ASSET MANAGEMENT LLC - TEVA PHARMACEUTICAL FIN LLC ownership

TEVA PHARMACEUTICAL FIN LLC's ticker is and the CUSIP is 88163VAE9. A total of 49 filers reported holding TEVA PHARMACEUTICAL FIN LLC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.6%.

Quarter-by-quarter ownership
WOLVERINE ASSET MANAGEMENT LLC ownership history of TEVA PHARMACEUTICAL FIN LLC
ValueSharesWeighting
Q4 2020$9,745,000
+1.5%
9,800,0000.0%0.07%
-15.3%
Q3 2020$9,603,000
+128.2%
9,800,000
+127.9%
0.08%
+102.4%
Q2 2020$4,208,000
+1402.9%
4,300,000
+1333.3%
0.04%
+950.0%
Q1 2020$280,000
-94.7%
300,000
-94.5%
0.00%
-93.4%
Q4 2019$5,240,0005,500,0000.06%
Other shareholders
TEVA PHARMACEUTICAL FIN LLC shareholders Q2 2020
NameSharesValueWeighting ↓
Radcliffe Capital Management, L.P. 70,783,000$69,363,0006.27%
INCOME RESEARCH & MANAGEMENT 14,978,000$14,536,0005.17%
PIPER SANDLER & CO. 5,000,000$4,852,0003.63%
Western Asset Management Company, LLC 42,946,000$42,102,0003.46%
PenderFund Capital Management Ltd. 4,000,000$5,225,0001.45%
Bracebridge Capital, LLC 5,500,000$5,335,0000.85%
WESTWOOD HOLDINGS GROUP INC 43,185,000$42,490,0000.54%
CORBYN INVESTMENT MANAGEMENT INC/MD 1,025,000$995,0000.52%
LMR Partners LLP 22,235,000$21,742,0000.45%
JUPITER ASSET MANAGEMENT LTD 35,000,000$34,357,0000.36%
View complete list of TEVA PHARMACEUTICAL FIN LLC shareholders